BNP Paribas Financial Markets
LKFT

BNP Paribas Financial Markets’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

BNP Paribas Financial Markets’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
11,292
+194
+2% +$6.42K ﹤0.01% 3794
2025
Q4 		$363K Sell
11,098
-756
-6% -$24.4K ﹤0.01% 3749
2025
Q3 		$411K Buy
11,854
+5,305
+81% +$170K ﹤0.01% 3655
2025
Q2 		$183K Sell
6,549
-879
-12% -$23.6K ﹤0.01% 3795
2025
Q1 		$187K Sell
7,428
-1,544
-17% -$39K ﹤0.01% 3742
2024
Q4 		$247K Buy
8,972
+2,824
+46% +$78.7K ﹤0.01% 3746
2024
Q3 		$177K Buy
6,148
+331
+6% +$9.01K ﹤0.01% 3296
2024
Q2 		$144K Buy
5,817
+489
+9% +$13.9K ﹤0.01% 3201
2024
Q1 		$172K Buy
5,328
+4,725
+784% +$176K ﹤0.01% 3295
2023
Q4 		$24.5K Buy
603
+296
+96% +$10.9K ﹤0.01% 3647
2023
Q3 		$10.6K Buy
307
+183
+148% +$7.12K ﹤0.01% 3621
2023
Q2 		$5.04K Buy
124
+21
+20% +$857 ﹤0.01% 3671
2023
Q1 		$3.98K Buy
103
+15
+17% +$617 ﹤0.01% 3599
2022
Q4 		$3.9K Buy
+88
New +$3.7K ﹤0.01% 3685
2022
Q3 		– Sell
-5,369
Closed -$300K – 4840
2022
Q2 		$300K Buy
+5,369
New +$318K ﹤0.01% 2914
2015
Q4 		– Sell
-2
Closed -$81 – 3593
2015
Q3 		$81 Buy
+2
New +$115 ﹤0.01% 3592

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BNP Paribas Financial Markets's LKFT Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 1.7% in Q1 2026, buying an estimated $6.42K and bringing the position to 11,292 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #3794.

BNP Paribas Financial Markets first reported a position in LKFT in Q3 2015 and has held it in 16 quarters since. The position peaked at $411K in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • BNP Paribas Financial Markets held 11,292 shares of Lakefront Biotherapeutics American Depositary Shares worth $339K as of Q1 2026.
  • BNP Paribas Financial Markets bought 194 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $6.42K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3794 holding.
  • BNP Paribas Financial Markets first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and has held it in 16 quarters since.
  • BNP Paribas Financial Markets's Lakefront Biotherapeutics American Depositary Shares position peaked at $411K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.